[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370811-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-370811-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","multiple-synchronous-primary-malignant-neoplasms-of-renal-ureter-and-urinary-bladder-a-case-report","Multiple synchronous primary malignant neoplasms of renal, ureter and urinary bladder - a case report","","A novel case describes synchronous multiple primary malignant neoplasms within the upper urinary tract. A 57-year-old male presented with asymptomatic gross hematuria and was diagnosed with three concurrent malignancies: papillary renal cell carcinoma (T1bN0M0), verrucous carcinoma of the renal pelvis (T1N0M0), and low-grade invasive urothelial carcinoma of the ureter (T2N0M0). Imaging showed a 5.7×5.2 cm renal mass and a 12 cm ureteral tumor extending into the bladder. After radical nephroureterectomy, histology confirmed all three primaries. Postoperative surveillance within four months identified metastatic progression and later development of bladder urothelial carcinoma.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/multiple-synchronous-primary-malignant-neoplasms-of-renal-ureter-and-urinary-bladder-a-case-report/370811/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/multiple-synchronous-primary-malignant-neoplasms-of-renal-ureter-and-urinary-bladder-a-case-report/370811.png","ImageObject",300,407,{"name":42,"@type":43},"Dipper","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",13,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What does the case report focus on clinically?","Question",{"text":63,"@type":64},"It focuses on synchronous multiple primary malignant neoplasms involving distinct histopathological entities in the upper urinary tract.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which three malignancies were diagnosed in the same patient?",{"text":68,"@type":64},"Papillary renal cell carcinoma (T1bN0M0), verrucous carcinoma of the renal pelvis (T1N0M0), and low-grade invasive urothelial carcinoma of the ureter (T2N0M0).",{"name":70,"@type":61,"acceptedAnswer":71},"What happened during postoperative follow-up?",{"text":72,"@type":64},"Within four months, surveillance identified metastatic progression to adrenal, retroperitoneal, and peritoneal regions, followed by subsequent development of bladder urothelial carcinoma.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},370811,1790230705,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":102,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1374404997633,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","TYPE Case Report  \nPUBLISHED 24 July 2025  \nDOI 10.3389/fonc.2025.1576764  \nOPEN ACCESS  \nEDITED BY  \nRonald M Bukowski,  \nCleveland Clinic, United States  \nREVIEWED BY  \nSri Manjari K,  \nOsmania University, India Rajesh Kumar,  \nKerala University of Health Sciences, India  \n*CORRESPONDENCE  \nGuangyong Li  \n [guangyongli1979@hotmail.com](guangyongli1979@hotmail.com)[ ](guangyongli1979@hotmail.com)Rui He  \n [ruihe515@163.com](ruihe515@163.com)  \n†These authors have contributed equally to this work  \nRECEIVED 14 February 2025  \nACCEPTED 27 June 2025  \nPUBLISHED 24 July 2025  \nCORRECTED 12 August 2025  \nCITATION  \nHuang B, Yin W, Al-Qaisi MA, Tian H, Zhao M, Zhang J, Deng C, Li N, He R and Li G (2025) Multiple synchronous primary malignant neoplasms of renal, ureter  \nand urinary bladder: a case report.  \nFront. Oncol. 15:1576764 .  \ndoi: 10.3389/fonc.2025.1576764  \nCOPYRIGHT  \n© 2025 Huang, Yin, Al-Qaisi, Tian, Zhao, Zhang, Deng, Li, He and Li. This is an openaccess article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nMultiple synchronous primary malignant neoplasms of renal, ureter and urinary bladder: a case report  \nBincheng Huang 1,2†, Wenhui Yin 1†,  \nMohammed Abdulkarem Al-Qaisi 1, Haifu Tian 1, Mengmeng Zhao 1,2, Jin Zhang 1, Chaodan Deng 2, Na Li 2, Rui He 2*† and Guangyong Li 1*†  \n1 Urology Department of General Hospital, Ningxia Medical University, Yinchuan, China, 2 Key Laboratory of Fertility Preservation and Maintenance of Ministry of Education, Ningxia Medical University, Yinchuan, China  \nSynchronous multiple primary malignant neoplasms (MPMNs) involving distinct histopathological entities within the upper urinary tract represent a rare clinical phenomenon. We present a novel case of a 57-year-old male presenting with asymptomatic gross hematuria, subsequently diagnosed with three concurrent malignancies: papillary renal cell carcinoma(T1bN0M0), verrucous carcinoma of the renal pelvis (T1N0M0), and low-grade invasive urothelial carcinoma of theureter (T2N0M0) . Comprehensive imaging evaluation revealed a 5 .7*5 . 2cm renal mass and 12cm ureteral tumor extending into the bladder. Following radical nephroureterectomy, histopathological conﬁrmation of three distinct primary malignancies was achieved. Postoperative surveillance identiﬁed metastatic progression to adrenal, retroperitoneal, and peritoneal regions within four months, with subsequent development of bladder urothelial carcinoma. The unusual coexistence of three histologically distinct upper urinary tract malignancies, particularly the rare verrucous carcinoma variant, provides novel insights into tumor biology and clinical management paradigms for genitourinary MPMNs.  \nKEYWORDS  \nsynchronous, MPMN, urinary, verrucous carcinoma, kidney  \nIntroduction  \nMPMNs encompass the concurrent or consecutive emergence of two or more distinct pathological tissue types within the same organ or tissue, or across various organs or tissues within the same individual (1).Recent advancements in tumor diagnosis and treatment technology have led to a perceived rise in clinical reports documenting MPMNs (2).This case is worth mentioning because the clustering offour primary malignancies (synchronous  \nFrontiers in Oncology 01 [frontiersin.org](frontiersin.org)  \nand metachronous) is of rare occurrence in a single patient and to our knowledge, this is the ﬁrst report of the combination of three synchronous primary cancers of the upper urinary tract appearing in the same patient.  \nIn this case report, we highlight a unique patient scenario characterized by the presence of three distinct histological types of","cbCailqtirWIU3Fs","https://ap.wps.com/l/cbCailqtirWIU3Fs","pdf",5153757,"English","# Introduction\n# Case report\n## Presentation and diagnostic workup\n## Surgical management and pathology\n## Postoperative surveillance and progression","[{\"question\":\"What does the case report focus on clinically?\",\"answer\":\"It focuses on synchronous multiple primary malignant neoplasms involving distinct histopathological entities in the upper urinary tract.\"},{\"question\":\"Which three malignancies were diagnosed in the same patient?\",\"answer\":\"Papillary renal cell carcinoma (T1bN0M0), verrucous carcinoma of the renal pelvis (T1N0M0), and low-grade invasive urothelial carcinoma of the ureter (T2N0M0).\"},{\"question\":\"What happened during postoperative follow-up?\",\"answer\":\"Within four months, surveillance identified metastatic progression to adrenal, retroperitoneal, and peritoneal regions, followed by subsequent development of bladder urothelial carcinoma.\"}]","Multiple synchronous primary malignant neoplasms of renal, ureter and urinary bladder - a case report | PDF",1790190483,15,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0a0dbe350a522d3b71cec714b50321c2.webp",983,1389,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7ecc17157d8df3854ccc051709697750.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/375dd460b6831fc69c21fe25bbde24a3.webp",981,1386,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ea035c621c853e331d5f36876a2ab8ee.webp",980,1385]